Monday, April 27, 2026 – MONDAY, April 27, 2026 — Regaining the weight you’ve just lost is a major risk for anyone who decides to stop taking Ozempic or Zepbound.But an experimental outpatient gut procedure might help people transition off their GLP-1 weight loss drug wit...
Monday, April 27, 2026 – Tuesday, April 28, - Glucagon-like peptide-1 receptor agonists, known as GLP-1 drugs, are highly effective at helping people lose weight and substantially lower the risk of heart attacks, strokes, and death from heart disease. A new study conducted in mice suggests that the drugs' effect on how blood vessels respond to insulin may be a key driver of this cardiovascular benefit in those with obesity.
Monday, April 27, 2026 – Tuesday, April 28, - The state of Covid-19 in 2026, a hat to treat depression, and other health news from Morning Rounds
Monday, April 27, 2026 – Tuesday, April 28, - Before the rise of GLP-1s, obesity experts didn’t study the internal buzz that compels people to eat. Now that food noise is being switched off, they want to understand it.
Saturday, April 25, 2026 – Saturday, April 25 - “We're basically not using our body as directed,” says "Drug Story" host Thomas Goetz.
Friday, April 24, 2026 – Saturday, April 25 - (MedPage Today) -- Cardiovascular protection with GLP-1 receptor agonists may benefit patients undergoing certain transcatheter procedures, according to two observational studies.
When used as an adjunct to transcatheter aortic valve replacement...
Friday, April 24, 2026 – Saturday, April 25 - The new generation of weight loss medicines does an unprecedented job of keeping off the pounds — if people stay on the drugs. Yet numerous studies suggest most of those who start taking GLP-1 drugs quit ...
Friday, April 24, 2026 – Saturday, April 25 - Teddi Mellencamp says her doctor denied her request for GLP-1s after steroid weight gain during her stage 4 melanoma treatment in a podcast discussion.
Friday, April 24, 2026 – Saturday, April 25 - GLP-1 drugs containing tirzepatide significantly reduce cardiovascular risks in people with serious heart conditions. Indranil MUKHERJEE / AFP via Getty Images
GLP-1 weight loss medications containing tirzepatide (Mounjaro, Zepbound) can reduce heart-related health risks for people with serious heart conditions, according to new research.
Thursday, April 23, 2026 – Friday, April 24 - (MedPage Today) -- Welcome to Culture Clinic, MedPage Today's collaboration with Northwell Health to offer a healthcare professional's take on the latest viral medical topics.
Many patients taking glucagon-like peptide-1 (GLP-1) receptor agonists...